Posts for GLAUKOS Corp ($GKOS)

Showing 1 - 3 of 3 Posts

Glaukos Corporation 2024 Financial Report: Revenue Growth vs. Rising Losses

$GKOS

•

Form 10-K

•

2025-02-25

Last updated: about 1 month ago

Glaukos Corporation 2024 Financial Report: Revenue Growth vs. Rising Losses

Explore Glaukos Corporation's 2024 financial challenges, with increased revenue but higher net losses. Investors advised to hold as they monitor operational efficiency.

Ophthalmic Sector Glaucoma Treatments Financial Analysis Revenue Growth Operational Efficiency

Glaukos Corporation 8-K Report: Key Updates for Investors - February 2025

$GKOS

•

Form 8-K

•

2025-02-20

Last updated: 2 months ago

Glaukos Corporation 8-K Report: Key Updates for Investors - February 2025

Explore Glaukos Corporation's latest 8-K report detailing significant corporate events on February 20, 2025. Stay informed about GKOS compliance and insights for investors.

Glaukos Corporation Glaucoma Treatment Medical Devices NYSE GKOS Regulatory Filings

Glaukos Corporation 8-K Report: Key Insights from January 14, 2025

$GKOS

•

Form 8-K

•

2025-01-14

Last updated: 4 months ago

Glaukos Corporation 8-K Report: Key Insights from January 14, 2025

Explore Glaukos Corporation's current report (Form 8-K) filed on January 14, 2025, detailing significant events affecting GKOS on the NYSE.

Glaukos Corporation Healthcare Medical Devices 8-K Filing NYSE GKOS

Financial Reports and Analysis for GLAUKOS Corp | SECsense